@article{9826eb687c7c47a1a38f1d92851f8213,
title = "Management of Vascular Sarcoma",
keywords = "Angiosarcoma, Epithelioid hemangioendothelioma, Hemangioendothelioma, Kaposi sarcoma, Vascular sarcoma",
author = "Aparna Subramaniam and Claudia Giani and Andrea Napolitano and Vinod Ravi and Frezza, {Anna Maria} and Jones, {Robin L.}",
note = "Funding Information: A. Napolitano reports financial support for an educational course from PharmaMar . V. Ravi reports grant funding to his institution in relation to clinical trial support from Athenex , Tracon , Novartis ; personal fees for consulting from Daiichi Sankyo, Guidepoint, GLG; royalties from UpToDate. A. M. Frezza reports research support to her institution from Advenchen Laboratories , Amgen Dompe , Arog Pharmaceuticals , Bayer , Blueprint Medicines , Daiichi Sankyo Pharma , Deciphera , Eli Lilly & Co , Epizyme , GlaxoSmithKline , Karyopharm Therapeutics , Novartis, Pfizer , PharmaMar, SpringWorks Therapeutics ; R. L. Jones reports grants and research support from Merck Sharp and Dohme Corp , GlaxoSmithKline ; consultation fees from Adaptimmune Therapeutics PLC, Astex Pharmaceuticals, Athenex, Bayer, Boehringer Ingelheim, Blueprint Medicines, Clinigen Group, Eisai Co Ltd, Epizyme, Daiichi Sankyo, Deciphera, Immune Design, Immunicum, Karma Oncology, Lilly, Merck Sharp and Dohme Corp, Mundipharma, PharmaMar, SpringWorks Therapeutics, SynOx Therapeutics, Tracon Pharmaceuticals, UpToDate. A. Subramaniam and C. Giani have no conflicts of interest to report.",
year = "2022",
month = jul,
doi = "10.1016/j.soc.2022.03.014",
language = "English (US)",
volume = "31",
pages = "485--510",
journal = "Surgical oncology clinics of North America",
issn = "1055-3207",
publisher = "W.B. Saunders Ltd",
number = "3",
}